Home › SEC Filings
SEC Filing Analysis
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| NEWT | 8-K | bearish | 6/10 | NewtekOne reported Q3 2026 GAAP diluted EPS of $0.34, down 49% from $0.67 a year ago, missing the $0.39 consensus. Reven | Oct 28, 2026 |
| TDOC | PRESS-RELEASE | bearish | 6/10 | Teladoc Health reported Q3 2026 revenue of $605.1M, down 3% YoY but above the $590.1M consensus. GAAP net loss per share | Oct 28, 2026 |
| LARK | 8-K | neutral | 4/10 | Landmark Bancorp reported Q3 2026 diluted EPS of $0.89, matching the consensus estimate of $0.89, with net earnings of $ | Oct 28, 2026 |
| FDX | 8-K | neutral | 3/10 | FedEx filed an 8-K with supplemental historical financial information recasting results for the change in fiscal year en | Oct 28, 2026 |
| CLPT | 8-K | bearish | 6/10 | ClearPoint Neuro reported Q3 2026 revenue of $12.1M (+36% YoY), in line with the $12.3M consensus, but GAAP EPS of -$0.2 | Oct 28, 2026 |
| NATH | SC 13D/A | neutral | 2/10 | GAMCO Investors, Inc. et al. filed a final amendment to their Schedule 13D for Nathan's Famous, Inc., reporting that the | Oct 28, 2026 |
| MBIN | 8-K | bullish | 6/10 | Merchants Bancorp reported Q3 2026 net income of $105.2M ($2.06 diluted EPS), up 92% YoY from $54.7M ($0.97) and up 34% | Oct 28, 2026 |
| JUSH | 8-K | neutral | 4/10 | Jushi Holdings reported Q3 2026 revenue of $70.5M, up 7% YoY, slightly below the $70.7M consensus. Net loss narrowed to | Oct 28, 2026 |
| SMTI | 425 | bearish | 6/10 | MiMedx Group reported Q3 2026 net sales of $62 million, down 45% YoY from $114 million, driven by a 71% decline in Wound | Oct 28, 2026 |
| NEWH | SC 13D | neutral | 5/10 | SunHydrogen, Inc. filed a Schedule 13D disclosing beneficial ownership of 610,950,000 shares of NewHydrogen common stock | Oct 28, 2026 |
| XYZ | 144 | neutral | 2/10 | Director Anthony Mathew Eisen filed a Form 144 notice of intent to sell 6,000 shares of Block, Inc. common stock, with a | Oct 28, 2026 |
| WTG | 8-K | neutral | 4/10 | Wintergreen Acquisition Corp. issued a $184,635 unsecured promissory note to its sponsor MACRO DREAM Holdings Limited to | Oct 28, 2026 |
| MSFT | 8-K | bullish | 6/10 | Microsoft reported strong fiscal Q1 2027 results, with revenue of $92.3 billion (+19% YoY) and GAAP diluted EPS of $4.92 | Oct 28, 2026 |
| BOOT | 8-K | neutral | 5/10 | Boot Barn reported Q2 FY2027 EPS of $1.73, beating the $1.63 consensus by 6.1%, on revenue of $581.8M, slightly above th | Oct 28, 2026 |
| TDOC | 8-K | bearish | 6/10 | Teladoc Health reported Q3 2026 revenue of $605.1M, down 3% YoY and above the $590.1M consensus. GAAP net loss per share | Oct 28, 2026 |
| TRUP | 144 | neutral | 2/10 | John R. Gallagher, an officer of Trupanion, Inc., filed a Form 144 notice of intent to sell 431 shares of common stock, | Oct 28, 2026 |
| SFM | 8-K | bearish | 6/10 | Sprouts Farmers Market reported Q3 2026 net sales of $2.30 billion (+5% YoY) but comparable store sales declined 0.9% an | Oct 28, 2026 |
| SPGI | 144 | neutral | 2/10 | Steven J. Kemps, an officer of S&P Global, filed a Form 144 notice of intent to sell 4,455 shares of common stock with a | Oct 28, 2026 |
| MDXG | 8-K | bearish | 6/10 | MiMedx reported Q3 2026 net sales of $62M, down 45% YoY from $114M, driven by a 71% decline in Wound sales due to Medica | Oct 28, 2026 |
| IZEA | DEF 14A | neutral | 3/10 | IZEA Worldwide, Inc. filed its definitive proxy statement for the 2026 annual meeting, seeking shareholder votes on dire | Oct 28, 2026 |
| WOLF | 8-K | neutral | 3/10 | Wolfspeed held its 2026 Annual Meeting on October 27, 2026, where all seven director nominees were elected, the 2026 Emp | Oct 28, 2026 |
| MDXG | PRESS-RELEASE | bearish | 6/10 | MiMedx reported Q3 2026 net sales of $62M, down 45% YoY from $114M, driven by a 71% decline in Wound Care sales due to M | Oct 28, 2026 |
| FIX | 8-K | neutral | 3/10 | Comfort Systems USA filed an 8-K to post an investor presentation on its website. The presentation highlights strong YTD | Oct 28, 2026 |
| ALGN | 8-K | neutral | 3/10 | Align Technology announced a CEO succession plan: Jennifer L. Davis, former CEO of P&G's Global Healthcare business, wil | Oct 28, 2026 |
| ADIL | PRESS-RELEASE | neutral | 5/10 | Adial Pharmaceuticals changed its name to Azora Therapeutics and will begin trading under ticker AZR on October 29, 2026 | Oct 28, 2026 |
| OBK | 8-K | bullish | 6/10 | Origin Bancorp reported Q3 2026 net income of $37.8M ($1.22 diluted EPS), up 11.6% from Q2 2026, with NIM-FTE expanding | Oct 28, 2026 |
| TMUS | 8-K | bullish | 6/10 | T-Mobile reported Q3 2026 results with diluted EPS of $3.22, above the consensus estimate of $2.91, and total revenues o | Oct 28, 2026 |
| REPL | 144 | neutral | 2/10 | Director Veleka Peeples-Dyer filed a Form 144 notice of intent to sell 12,000 shares of Replimune Group common stock, va | Oct 28, 2026 |
| MYRG | 8-K | bullish | 6/10 | MYR Group reported record Q3 2026 revenue of $1.26B (up 32.5% YoY) and diluted EPS of $3.82 (up 86.3% YoY), both well ab | Oct 28, 2026 |
| FORM | 8-K | bullish | 6/10 | FormFactor reported Q3 2026 revenue of $280.5M (up 38.4% YoY) and non-GAAP EPS of $1.04, both exceeding the high end of | Oct 28, 2026 |